CAR T-Cell Therapy Enabled Successful Pregnancies
Women with autoimmune diseases discontinued immunosuppressive medications following treatment in a recent study.
Updated on Sept. 22, 2026 in Pregnancy
Live Poll
Do you trust that new medical therapies adequately prioritize patient safety during long-term health management?
International researchers found that women with autoimmune diseases were able to experience healthy pregnancies after receiving CAR T-cell therapy. The study documented 14 pregnancies and 8 births with no reported complications for the mothers or infants.
Why it matters
Autoimmune conditions and the medications used to manage them often create significant barriers to pregnancy, as untreated disease activity can damage vital organs. This approach offers a potential new path for those whose disease management previously complicated their ability to conceive.
A study published in the New England Journal of Medicine tracked 14 pregnancies in women with autoimmune diseases who underwent CD19 CAR T-cell therapy. All 8 births resulted in healthy infants who developed age-appropriate immune systems.
The players
New England Journal of Medicine
A leading peer-reviewed medical journal that publishes clinical research and health policy updates.
The details
The treatment utilizes CD19 CAR T-cell therapy to systematically eliminate B cells that drive autoimmune disease activity. By resetting the immune system through this depletion, patients in the study were able to safely stop taking immunosuppressive medications without experiencing disease recurrence during their pregnancies.
Timeline
September 22, 2026: Research findings were published in the NEJM.
Health Landscape
CD19 CAR T-cell therapy has historically been reserved for oncology, but this research highlights its emerging potential to induce long-term remission in autoimmune conditions. This development represents a pivot in how medicine approaches treating systemic disease in patients of reproductive age.
If you are currently managing an autoimmune condition and have concerns about pregnancy or immunosuppressive treatments, this study highlights an area of evolving research worth discussing with your doctor. Always consult your specialist to understand the risks and eligibility for new treatment options.
The takeaway
This study suggests that depleting specific B cells can create a window for healthy pregnancy in women who would otherwise be limited by autoimmune disease. Individuals with these conditions should prioritize conversations with their rheumatologist about current fertility-related treatment guidelines.
Further reading
Learn more about managing reproductive health in the Pregnancy section.
More information
Review the full NEJM study on CAR T-cell pregnancies for additional data.
Live Poll
Do you trust that new medical therapies adequately prioritize patient safety during long-term health management?
